RESMED INC
Close on Oct 19, 2026
- Market cap
- $34.79B
- P/E (TTM)
- 23.0
- Dividend yield
- 1.00%
About Resmed
Surgical & Medical Instruments & Apparatus, SIC 3841
ResMed Inc. develops digital health solutions, cloud-connected medical devices, and care management software platforms. The company operates through two business segments: Sleep and Breathing Health, and Residential Care Software. Its core offering includes continuous positive airway pressure systems, bilevel and adaptive servo-ventilation equipment, ventilators, diagnostic products, mask systems, and cloud applications like AirView and myAir. In addition, it provides residential care management platforms, including Brightree and MEDIFOX DAN. Its solutions serve individuals with sleep apnea and respiratory conditions, alongside clinicians, durable medical equipment suppliers, and residential healthcare organizations.
The company conducts commercial operations globally, distributing products across more than 140 countries through wholly owned operating subsidiaries and independent distributors, supported by approximately 11,370 employees worldwide. ResMed Inc. was incorporated under Delaware law as the ultimate holding company for its operating subsidiaries, while the provided text does not state a specific city or physical headquarters location.
Summary of the business section of Resmed's latest annual report, written by StockData.
Company profile
Company
- Legal name
- RESMED INC
- Founded
- 1989
- Headquarters
- San Diego, CA
- Address
- 9001 Spectrum Center Blvd. 92123
- Phone
- (858) 746-2400
- Website
- resmed.com
- Employees
- 11,370, Jun 30, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- June 30
- Auditor
- KPMG LLP, San Diego, CA
Stock & identifiers
- Ticker
- RMD
- Other tickers
- RSMDF
- Exchange
- NYSE
- Shares outstanding
- 144M, Aug 10, 2026
- Public float
- $34.92B, Dec 31, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Aug 31, 2010; 2-for-1, Oct 3, 2005; 2-for-1, Apr 3, 2000; 2-for-1, Nov 17, 1998
- SEC CIK
- 943819
- CUSIP
- 761152107
- ISIN
- US7611521078
- LEI
- 529900T3QE5253CCXF22
- EIN
- 98-0152841
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael J. Farrell | Chairman and CEO, Director | 468,346 |
| Michael J. Rider | Global General Counsel | 9,488 |
| Brett Sandercock | Chief Financial Officer | 83,495 |
| Aaron Bloomer | Chief Financial Officer | – |
| Justin Leong | Chief Product Officer | 29,028 |
| Kaushik Ghoshal | Chief Commercial Officer, SaaS | 19,430 |
| Peter C. Farrell | Director | 1,095,977 |
| Witte Jan De | Director | 4,261 |
| Nicole Mowad-Nassar | Director | 777 |
| Karen Drexler | Director | 10,602 |
| Christopher DelOrefice | Director | 2,423 |
| Carol Burt | Director | 18,816 |
| John Hernandez | Director | 5,118 |
| Desney Tan | Director | 6,002 |
| Ronald R. Taylor | Director | 24,771 |
| Harjit Gill | Director | 10,940 |
| Richard Sulpizio | Director | 17,796 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr. Michael Farrell | $14.67M | $29.63M | $3.36M | $134 | $150 |
| FY2024 Mr. Michael Farrell | $14.12M | $10.33M | $3.13M | $100 | $132 |
| FY2023 Mr. Michael Farrell | $13.87M | $16.87M | $4.15M | $114 | $130 |
| FY2022 Mr. Michael Farrell | $11.66M | $4.37M | $3.63M | $109 | $114 |
| FY2021 Mr. Michael Farrell | $10.39M | $32.80M | $4.17M | $128 | $135 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of June 30, 2026, we had approximately 11,370 employees, of which approximately 4,590 were employed in cost of sales activities including areas such as warehousing and manufacturing, 2,300 in research and development and 4,480 in sales, marketing and administration.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 17, 2026 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Nov 14, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 4, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 27, 2008 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 24, 2005 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 21, 1999 | Listing | Registration of securities on an exchange (Form 8-A) |